Global Health: A Look Ahead at Trends in Seven Key Areas
Client Alert | 1 min read | 04.07.22
Crowell & Moring International (CMI) commemorates “World Health Day” with the publication of our compiled health policy forecast for the year. “Global Health: A Look Ahead at Trends in Seven Key Areas” explores global health trends and challenges at the forefront of business, government and public concerns.
This forecast provides a concise outlook on key issues affecting health in 2022 and beyond. Each is an area where CMI works with our partners to make a meaningful difference. Each is an area that merits attention and concerted action to improve health. We offer our perspectives on:
- Vaccines
- Health Financing
- Antimicrobial Resistance (AMR)
- Oncology/Cervical Cancer
- Women’s Health
- Rare Diseases
- AI/Digital Health
Based in Washington, DC and Singapore, C&M International has a commitment to advancing health through our work with clients to help shape policy, regulatory, and commercial landscapes around the global. For more information on C&M International and its capabilities, please visit cmintl.com.
Contacts
Insights
Client Alert | 6 min read | 11.26.25
From ‘Second’ to ‘First:’ Federal Circuit Tackles Obvious Claim Errors
Patent claims must be clear and definite, as they set the boundaries of the patentee’s rights. Occasionally, however, claim language contains errors, such as typographical mistakes or incorrect numbering. Courts possess very limited authority to correct such errors. The United States Court of Appeals for the Federal Circuit has emphasized that judicial correction is appropriate only in rare circumstances, where (1) the error is evident from the face of the patent, and (2) the proposed correction is the sole reasonable interpretation in view of the claim language, specification, and prosecution history. See Group One, Ltd. v. Hallmark Cards, Inc., 407 F.3d 1297, 1303 (Fed. Cir. 2005) and Novo Indus., L.P. v. Micro Molds Corp., 350 F.3d 1348, 1357 (Fed. Cir. 2003).
Client Alert | 5 min read | 11.26.25
Client Alert | 6 min read | 11.25.25
Brussels Court Clarifies the EU’s SPC Manufacturing Waiver Regulation Rules
Client Alert | 3 min read | 11.24.25
